Hrt Financial LP Bio Path Holdings Inc Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$0.36 - $0.75 $226 - $471
-629 Reduced 3.51%
17,294 $8,000
Q3 2023

Nov 13, 2023
BUY
$0.36 - $1.78 $6,452 - $31,902
17,923 New
17,923 $6,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $5.51M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email